Adenovirus mediated alpha interferon (IFN-α) gene transfer into CD34+ cells and CML mononuclear cells

Stem Cells

Volumn 15, Issue 5, 1997, Pages 386-395

  Feldman, E ^a   Ahmed, T ^a   Lutton, J D ^a   Farley, T ^a   Tani, K ^b   Freund, M ^c   Asano, S ^b   Abraham, N G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Gene transfer; Leukemia; Stem cells; interferon

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; CYTOMEGALOVIRUS; MAMMALIA;

EID: 0030865137     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150386     Document Type: Article

References (46)

1. Chertkov JL, Jiang S, Lutton JD et al. The hematopoietic stromal microenvironment promotes retrovinis-mediated gene transfer into hematopoietic stem cells. STEM CELLS 1993;11:218-227.
2. Dunbar CE, Emmons RV. Gene transfer to hematopoietic progenitor and stem cells: progress and problems. STEM CELLS 1994;12:563-570.
3. Mulligan RC. The basic science of gene therapy. Science 1994;260:926-932.
4. Hanania EG, Kavanagh J, Hortogagyi G et al. Recent advance in the application of gene therapy to human disease. Am J Med 1995;99:537-552.
5. Christal RG, McElvaney NG, Rosenfeld MA et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994;8:42-51.
6. Watanabe T, Kiszynski C, Ino K et al. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Blood 1996;87:5032-5036.
7. Haddada H, Lopez M, Martinache C et al. Efficient adenovirus-mediated gene transfer into human blood monocytederived macrophages. Biochem Biophy Res Commun 1993;195:1174-1183.
8. Mitani K, Graham FL, Caskey CT. Transduction of human bone marrow by adenoviral vector. Hum Gene Ther 1994;5:941-948.
9. Abraham NG, da Silva J-L, Lavrovsky Y et al. Adenovirusmediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci 1995;36:2202-2210.
10. Ohwada A, Rafii S, Moore MAS et aJ. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression. Blood 1996;88:778-784.
11. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977;63:125-130.
12. Martin PJ, Najfield V, Hansen JA et al. Involvement of the B-lymphoid system in chronic myelogenous leukemia. Nature 1980;287:49-50.
13. Nitta M, Kato Y, Strife A et al. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood 1985;66:1053-1061.
14. McGlave PB, Bartsch G, Anasetti C et al. Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program (NMDP). Blood 1993;81:543-550.
15. Snyder DS, McGlave PB. Treatment of chronic myelogenous leukemia with bone marrow transplantation. Hematol Oncol Clin North Am 1990;4:53-57.
16. McWhirter JR, Wang JYI. Activation of tyrosine kinase and microfilament-binding functions by c-able by bcr sequences in bcr/abl fusion protein. Mol Cell Biol 1991;11:1553-1565.
17. Gordon MY, Dowding CR, Riley GP et al. Altered adhesive interactions with marrow stroma of haematopoietic cells in chronic myeloid leukemia. Nature 1987;328:342-345.
18. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J Clin Invest 1992;90:1232-1241.
19. Wetzler M, Kurzrock R, Lowe DG et al. Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. Blood 1991;78:2400-2406.
20. Bhatia R, McGlave PB, Dewald GW et al. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 1995;85:3636-3645.
21. Bhatia R, McCarthy JB, Varfaillie CM. Interferon-α restores normal b1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood 1996;87:3883-3891.
22. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994;330:820-825.
23. Broxmeyer HE, Lu E, Platzer E et al. Comparative analyses of the influences of human gamma, alpha and beta inteferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte macrophage (CFU-GM) progenitor cells. J Immunol 1983;131:1330-1335.
24. Geissler D, Gastl G, Aulitzky W et al. Recombinant interferon-alpha-2C in chronic myelogenous leukemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response. Leuk Res 1990;14:629-636.
25. Upadhyaya G, Guba SC, Sih SA et al. Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 1991;88:2131-2136.
26. Dowding C, Guo AP, Osterholz J et al. Interferon-alpha overrides the deficient adhesion of chronic myelogenous leukemia primitive progenitor cells to bone marrow stromal cells. Blood 1991;78:499-505.
27. Bhatia R, McGlave P, Verfaillie CM. Treatment of marrow stroma with interferon-α restores normal b1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1α. J Clin Invest 1995;96:931.
28. Aman MJ, Keller U, Derigs G et al. Regulation of cytokine expression by interferon alpha in human bone marrow stroma cells: inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood 1994;84:4142-4150.
29. Bhatia R, McGlave PB, Verfaillie CM. Interferon-α treatment of marrow stroma results in enhanced adhesion of chronic myelogenous leukemia progenitors via mechanism involving MIP-1α and TGF-β. Exp Hematol 1994;22:797a.
30. Zoumbos N, Gascon P, Young NS. The induction of lymphocytes in normal and suppressed hematopoiesis. Blut 1984;48:1-9.
31. Emerson SG, Antin JH. Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte response. J Immunol 1989;142:766-772.
32. Eaves CJ, Cashman JD, Eaves AC et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991;78:110-117.
33. Hanabuchi S, Koyanagi M, Kawasaki A et al. Fas and its ligand is a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994;91:4930-4934.
34. Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology. New York: John Wiley & Sons, 1987:121 -132.
35. Brandt J, Srour EF, van Besien K et al. Cytokine dependent long term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 1990;86:932-941.
36. Verfaillie C, McGlave PB. Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hemopoietic progenitors. Blood 1991;77:263-270.
37. Verfaillie C, Blakholmer K, McGlave P. Purified primitive human hematopoietic progenitors with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 1990;179:509-520.
38. + marrow cells engraft lethally irradiated baboons. J Clin Invest 1988;81:951-956.
39. Verfaillie CM, Miller WJ, Boylan K et al. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of DR antigen expression. Blood 1992;79:1003-1008.
40. Goodman AI, Choudhury M, da Silva J-L et al. Quantitative measurement of heme oxygenase-1 in the human adenocarcinoma. J Cell Biochem 1996;63:342-348.
41. Chomczyski R, Sacchi N. Single-step method of RNA isolation by acid guanidium isothiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
42. Huang S, Endo RI, Nemerow GR. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995;69:2257-2263.
43. Talpaz M, Kantarjiian H, Kurzrock R et al. Interferon-alpha produced sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 1991;114:532-538.
44. Leemhuis T, Liebowitz D, Cox G et al. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 1993;81:801-807.
45. BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines. Blood 1993;81:502-509.
46. Conneally E, Bardy P, Eaves CJ et al. Rapid and efficient selection of human hematopoietic cells expressing murine heat state antigen as an indicator of retroviral-mediated gene transfer. Blood 1996;87:456-464.